14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of STAB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Statera Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Statera Biopharma, Inc. is STAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Statera Biopharma, Inc. Stock.

What's the current price of Statera Biopharma, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Statera Biopharma, Inc. (STAB) share was $0.0007.

What is the 52-week high and low for Statera Biopharma, Inc. Stock?
The 52-week high for Statera Biopharma, Inc. Stock is $0.0380 and the 52-week low is $0.000001.

What is the market capitalization of Statera Biopharma, Inc. Stock?
As of the May 01, 2024, the market capitalization of Statera Biopharma, Inc. is 49.991K.

When is the next earnings date for Statera Biopharma, Inc.?
The upcoming earnings date for Statera Biopharma, Inc. is May 17, 2024.
Click to get the best stock tips daily for free!

About Statera Biopharma, Inc.

Statera Biopharma. Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm... STAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT